| Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases LGM van der Geest, J Lam-Boer, M Koopman, C Verhoef, MAG Elferink, ... Clinical & experimental metastasis 32, 457-465, 2015 | 576 | 2015 |
| Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study A Méndez Romero, W Wunderink, SM Hussain, JA De Pooter, ... Acta oncologica 45 (7), 831-837, 2006 | 564 | 2006 |
| Body composition and outcome in patients undergoing resection of colorectal liver metastases MG Van Vledder, S Levolger, N Ayez, C Verhoef, TCK Tran, ... Journal of British Surgery 99 (4), 550-557, 2012 | 512 | 2012 |
| The PD-1/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes F Dammeijer, M van Gulijk, EE Mulder, M Lukkes, L Klaase, ... Cancer cell 38 (5), 685-700. e8, 2020 | 489 | 2020 |
| Clinical relevance of melanoma micrometastases (< 0.1 mm) in sentinel nodes: are these nodes to be considered negative? ACJ van Akkooi, JHW de Wilt, C Verhoef, PIM Schmitz, AN van Geel, ... Annals of oncology 17 (10), 1578-1585, 2006 | 343 | 2006 |
| Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients … ACJ van Akkooi, ZI Nowecki, C Voit, G Schäfer-Hesterberg, W Michej, ... Annals of surgery 248 (6), 949-955, 2008 | 321 | 2008 |
| Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience P Rutkowski, A Gronchi, P Hohenberger, S Bonvalot, P Schöffski, S Bauer, ... Annals of surgical oncology 20, 2937-2943, 2013 | 307 | 2013 |
| Surveillance after curative treatment for colorectal cancer EP van der Stok, MCW Spaander, DJ Grünhagen, C Verhoef, EJ Kuipers Nature reviews Clinical oncology 14 (5), 297-315, 2017 | 270 | 2017 |
| Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population‐based series AEM Van der Pool, RA Damhuis, JNM Ijzermans, JHW de Wilt, ... Colorectal Disease 14 (1), 56-61, 2012 | 269 | 2012 |
| Total pelvic exenteration for primary and recurrent malignancies FTJ Ferenschild, M Vermaas, C Verhoef, AC Ansink, WJ Kirkels, ... World journal of surgery 33, 1502-1508, 2009 | 266 | 2009 |
| Prognosis in patients with sentinel node–positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria APT van der Ploeg, ACJ van Akkooi, P Rutkowski, ZI Nowecki, W Michej, ... Journal of clinical oncology 29 (16), 2206-2214, 2011 | 240 | 2011 |
| Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study RCH Stijns, EJR de Graaf, CJA Punt, ID Nagtegaal, JJME Nuyttens, ... JAMA surgery 154 (1), 47-54, 2019 | 228 | 2019 |
| International consensus guidelines for scoring the histopathological growth patterns of liver metastasis PJ Van Dam, EP Van Der Stok, LA Teuwen, GG Van den Eynden, ... British journal of cancer 117 (10), 1427-1441, 2017 | 228 | 2017 |
| Stereotactic body radiation therapy for colorectal liver metastases AEM Van der Pool, A Méndez Romero, W Wunderink, BJ Heijmen, ... Journal of British Surgery 97 (3), 377-382, 2010 | 220 | 2010 |
| Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study) M Verseveld, EJR De Graaf, C Verhoef, E van Meerten, CJA Punt, ... Journal of British Surgery 102 (7), 853-860, 2015 | 216 | 2015 |
| Activated tumor‐infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer A Pedroza‐Gonzalez, C Verhoef, JNM Ijzermans, MP Peppelenbosch, ... Hepatology 57 (1), 183-194, 2013 | 213 | 2013 |
| Characteristics of early-onset vs late-onset colorectal cancer: a review R Collaborative, AM Zaborowski, A Abdile, M Adamina, F Aigner, ... JAMA surgery 156 (9), 865-874, 2021 | 210 | 2021 |
| Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer results from an international collaboration ME Kelly, R Glynn, AG Aalbers, W Alberda, A Antoniou, KK Austin, ... | 210 | 2019 |
| Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer Journal of British Surgery 105 (6), 650-657, 2018 | 189 | 2018 |
| Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer M Vermaas, FTJ Ferenschild, C Verhoef, J Nuyttens, A Marinelli, ... European Journal of Surgical Oncology (EJSO) 33 (4), 452-458, 2007 | 186 | 2007 |
